Publication:
Piperidine-based natural products targeting Type IV pili antivirulence: a computational approach

dc.contributor.coauthorOzcan, Aslihan
dc.contributor.coauthorAkbulut, Berna Sariyar
dc.contributor.coauthorOzbek, Pemra
dc.contributor.departmentDepartment of Chemical and Biological Engineering
dc.contributor.kuauthorKeskin, Özlem
dc.contributor.kuprofileFaculty Member
dc.contributor.otherDepartment of Chemical and Biological Engineering
dc.contributor.schoolcollegeinstituteCollege of Engineering
dc.contributor.yokid26605
dc.date.accessioned2024-11-09T22:51:16Z
dc.date.issued2023
dc.description.abstractType IV (T4) pilus is among the virulence factors with a key role in serious bacterial diseases. Specifically, in Neisseria meningitidis and Pseudomonas aeruginosa, it determines pathogenicity and causes infection. Here, a computational approach has been pursued to find piperidine-based inhibitor molecules against the elongation ATPase of T4 pili in these two selected pathogens. Using the modeled structures of the PilF and PilB ATPases of N. meningitidis and P. aeruginosa, virtual library screening via molecular docking has returned inhibitor molecule candidates. The dynamics of the best three binders have further been investigated in detail via molecular dy-namic simulations. Among these, ligands with COCONUT IDs CNP0030078 and CNP0051517 were found to have higher potential in the inhibition of ATPases based on molecular dynamic simulation analysis and biological activity information. The obtained results will guide future efforts in antivirulence drug development against T4 pili of N. meningitidis and P. aeruginosa.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [120M225] Scientific and Technological Research Council of Turkey (TUBITAK) Project Number 120M225 is highly acknowledged. A.O. acknowledges YOK 100/2000.
dc.description.volume119
dc.identifier.doi10.1016/j.jmgm.2022.108382
dc.identifier.eissn1873-4243
dc.identifier.issn1093-3263
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85143376609
dc.identifier.urihttp://dx.doi.org/10.1016/j.jmgm.2022.108382
dc.identifier.urihttps://hdl.handle.net/20.500.14288/6819
dc.identifier.wos894858500001
dc.keywordsAntivirulence
dc.keywordsDrug discovery
dc.keywordsMolecular docking
dc.keywordsMolecular dynamics simulations
dc.keywordsNatural product
dc.keywordsPilB
dc.keywordsPilF
dc.keywordsPiperidine
dc.keywordsType IV pili
dc.keywordsVirtual library screening
dc.languageEnglish
dc.publisherElsevier
dc.sourceJournal of Molecular Graphics and Modelling
dc.subjectBiochemical research Methods
dc.subjectBiochemistry
dc.subjectMolecular biology
dc.subjectComputer science
dc.subjectCrystallography
dc.subjectMathematical and computational biology
dc.titlePiperidine-based natural products targeting Type IV pili antivirulence: a computational approach
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-4202-4049
local.contributor.kuauthorKeskin, Özlem
relation.isOrgUnitOfPublicationc747a256-6e0c-4969-b1bf-3b9f2f674289
relation.isOrgUnitOfPublication.latestForDiscoveryc747a256-6e0c-4969-b1bf-3b9f2f674289

Files